Search Results - "Undas, A."

Refine Results
  1. 1
  2. 2

    Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study by Malec, K, Broniatowska, E, Undas, A

    Published in Lupus (01-01-2020)
    “…Objectives Despite controversies, direct oral anticoagulants (DOACs) are increasingly used in antiphospholipid syndrome (APS). We investigated the safety and…”
    Get full text
    Journal Article
  3. 3

    Detection of titanium particles in human liver and spleen and possible health implications by Heringa, M B, Peters, R J B, Bleys, R L A W, van der Lee, M K, Tromp, P C, van Kesteren, P C E, van Eijkeren, J C H, Undas, A K, Oomen, A G, Bouwmeester, H

    Published in Particle and fibre toxicology (11-04-2018)
    “…Titanium dioxide (TiO ) is produced at high volumes and applied in many consumer and food products. Recent toxicokinetic modelling indicated the potential of…”
    Get full text
    Journal Article
  4. 4

    Antithrombotic medications and their impact on fibrin clot structure and function by Undas, A, Zabczyk, M

    “…Fibrin constitutes a major protein component of intravascular thrombi in all locations. Fibrin formation and its functions are essential for physiological…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome by Siudut, J., Grela, M., Wypasek, E., Plens, K., Undas, A.

    Published in Journal of thrombosis and haemostasis (01-04-2016)
    “…Essentials The postthrombotic syndrome (PTS) is a common complication of deep vein thrombosis (DVT). Plasma fibrin clot properties were assessed in patients…”
    Get full text
    Journal Article
  7. 7

    Anticoagulant effects of statins and their clinical implications by Undas, A, Brummel-Ziedins, K E, Mann, K G

    Published in Thrombosis and haemostasis (03-03-2014)
    “…There is evidence indicating that statins (3-hydroxy-methylglutaryl coenzyme A reductase inhibitors) may produce several cholesterol-independent antithrombotic…”
    Get more information
    Journal Article
  8. 8

    Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid by Undas, A., Brummel‐Ziedins, K., Mann, K. G.

    Published in Journal of thrombosis and haemostasis (01-11-2014)
    “…Summary It is well established that aspirin, an irreversible inhibitor of platelet cyclooxygenase activity, is effective in secondary prevention of arterial…”
    Get full text
    Journal Article
  9. 9

    Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome by Kopytek, M, Natorska, J, Undas, A

    Published in Lupus (01-04-2018)
    “…Objectives Antibodies to phosphatidylserine/prothrombin complex (aPS/PT) detectable in sera of some patients with antiphospholipid syndrome (APS) have been…”
    Get full text
    Journal Article
  10. 10

    Asthma is associated with enhanced thrombin formation and impaired fibrinolysis by Bazan-Socha, S., Mastalerz, L., Cybulska, A., Zareba, L., Kremers, R., Zabczyk, M., Pulka, G., Iwaniec, T., Hemker, C., Undas, A.

    Published in Clinical and experimental allergy (01-07-2016)
    “…Summary Background There is evidence that altered blood coagulation and fibrinolysis are involved in the pathogenesis of asthma. Increased thromboembolic risk…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect by Morena‐Barrio, M. E., Martínez‐Martínez, I., Cos, C., Wypasek, E., Roldán, V., Undas, A., Scherpenzeel, M., Lefeber, D. J., Toderici, M., Sevivas, T., España, F., Jaeken, J., Corral, J., Vicente, V.

    Published in Journal of thrombosis and haemostasis (01-08-2016)
    “…Essentials We investigated the molecular base of antithrombin deficiency in cases without SERPINC1 defects. 27% of cases presented hypoglycosylation, transient…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Impaired fibrinolysis is associated with the severity of aortic stenosis in humans by Natorska, J., Wypasek, E., Grudzień, G., Sadowski, J., Undas, A.

    Published in Journal of thrombosis and haemostasis (01-04-2013)
    “…Summary Background A role of fibrinolysis in the pathogenesis of aortic valve stenosis (AS) is unknown, although fibrinolytic proteins have been detected in…”
    Get full text
    Journal Article
  15. 15

    Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease by UNDAS, A., CELINSKA‐LÖWENHOFF, M., LÖWENHOFF, T., SZCZEKLIK, A.

    Published in Journal of thrombosis and haemostasis (01-05-2006)
    “…Background: Aspirin increases fibrin clot porosity and susceptibility to lysis. It is unknown whether other drugs, in combination with aspirin, used in the…”
    Get full text
    Journal Article
  16. 16

    Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition by BRUMMEL‐ZIEDINS, K., UNDAS, A., ORFEO, T., GISSEL, M., BUTENAS, S., ZMUDKA, K., MANN, K. G.

    Published in Journal of thrombosis and haemostasis (01-01-2008)
    “…Background: Acute coronary syndrome (ACS) is associated with thrombin formation, triggered by ruptured or eroded coronary atheroma. We investigated whether…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20